The higher levels of acetate in the blood described in this group of patients, who are at high risk of developing osteoporosis (38, 77–79), could trigger adipocyte differentiation and thus prevent osteoblast differentiation of mesenchymal stem cells via Gpr41/43. Here, FFAR3 is linked to osteoporosis.